BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $859,717 | -49.7% | 22,780 | -39.3% | 0.01% | -47.4% |
| Q2 2023 | $1,710,095 | -29.2% | 37,535 | -36.9% | 0.02% | -34.5% |
| Q1 2023 | $2,414,293 | -97.2% | 59,524 | -96.5% | 0.03% | -97.3% |
| Q4 2022 | $85,864,134 | -14.4% | 1,684,601 | -9.6% | 1.06% | -23.1% |
| Q3 2022 | $100,349,000 | -15.7% | 1,863,139 | +0.5% | 1.38% | -11.3% |
| Q2 2022 | $119,019,000 | -16.0% | 1,853,007 | +1.5% | 1.55% | -5.2% |
| Q1 2022 | $141,622,000 | -6.8% | 1,826,434 | +3.1% | 1.64% | -1.2% |
| Q4 2021 | $152,008,000 | +5.6% | 1,770,825 | -1.0% | 1.66% | -3.8% |
| Q3 2021 | $143,901,000 | -49.3% | 1,789,148 | -6.1% | 1.72% | +3.0% |
| Q2 2021 | $283,916,000 | +94.2% | 1,905,405 | +9.9% | 1.67% | -10.7% |
| Q1 2021 | $146,211,000 | +41.1% | 1,733,586 | +34.2% | 1.87% | +27.8% |
| Q4 2020 | $103,630,000 | +4.3% | 1,291,497 | +4.5% | 1.46% | -7.6% |
| Q3 2020 | $99,356,000 | -3.6% | 1,235,459 | +3.2% | 1.58% | -10.4% |
| Q2 2020 | $103,077,000 | +11.3% | 1,197,182 | +5.0% | 1.77% | -6.0% |
| Q1 2020 | $92,614,000 | -1.7% | 1,140,703 | +1.3% | 1.88% | +23.3% |
| Q4 2019 | $94,172,000 | -4.6% | 1,126,193 | -0.2% | 1.53% | -11.8% |
| Q3 2019 | $98,662,000 | +7.5% | 1,127,952 | +0.6% | 1.73% | +5.1% |
| Q2 2019 | $91,808,000 | +1.7% | 1,120,978 | +1.0% | 1.65% | -1.7% |
| Q1 2019 | $90,258,000 | +25.8% | 1,110,047 | +1.9% | 1.68% | +9.7% |
| Q4 2018 | $71,731,000 | -13.6% | 1,089,808 | +1.2% | 1.53% | -0.4% |
| Q3 2018 | $83,055,000 | +3.8% | 1,077,375 | -0.6% | 1.53% | -3.0% |
| Q2 2018 | $80,021,000 | +12.0% | 1,083,708 | -1.3% | 1.58% | +10.6% |
| Q1 2018 | $71,447,000 | -0.1% | 1,098,510 | -0.7% | 1.43% | +1.9% |
| Q4 2017 | $71,495,000 | +1.7% | 1,106,050 | -1.2% | 1.40% | -4.4% |
| Q3 2017 | $70,275,000 | +3.8% | 1,119,918 | +0.1% | 1.47% | -0.7% |
| Q2 2017 | $67,727,000 | +17.9% | 1,118,708 | +1.0% | 1.48% | +12.7% |
| Q1 2017 | $57,433,000 | +17.2% | 1,107,459 | +0.2% | 1.31% | +10.4% |
| Q4 2016 | $49,021,000 | -6.4% | 1,105,567 | +0.4% | 1.19% | -9.0% |
| Q3 2016 | $52,389,000 | +5.8% | 1,100,615 | +0.5% | 1.31% | +5.1% |
| Q2 2016 | $49,507,000 | +12.6% | 1,094,794 | +2.3% | 1.24% | +8.7% |
| Q1 2016 | $43,959,000 | +2541.8% | 1,070,091 | +4372.7% | 1.14% | +2334.0% |
| Q4 2013 | $1,664,000 | +3.7% | 23,925 | -2.0% | 0.05% | -19.0% |
| Q3 2013 | $1,604,000 | +491.9% | 24,425 | +522.3% | 0.06% | +544.4% |
| Q2 2013 | $271,000 | – | 3,925 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |